<DOC>
	<DOCNO>NCT02181192</DOCNO>
	<brief_summary>PSA-recurrence prostate carcinoma associate two general problem . 1 . Localisation PSA-recurrence unconfident . In many case 's clear local , locoregional oder systemic relapse available . 2 . There standard therapy prove randomised clinical trial . Recommended radiotherapy start PSA-value &lt; 0.5 ng/ml accord german S3 guideline base retrospective data . These difficulty may lead therapy potentially adapt patient situation disease.This study aim randomise examine instant radiotherapy prostate PSA-recurrence ( PSA-value 0.2 - 0.99 ng/ml ) delay radiotherapy additional imaging ( PSA value &gt; = 1 ng/ml ) include PET/CT bone scintigraphy reliable information tumor location expansion beneficial regard therapy efficiency , quality life social economic aspect .</brief_summary>
	<brief_title>Point Time Radiotherapy Patients With Biochemical Recurrent Prostate Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>postoperative , biochemical recurrent prostate carcinoma PSA value 0.2 0.99 ng/ml prior irradiation comprehension study protocol content sign informed consent form minimum age 18 year primary therapy prostate carcinoma PSA value &gt; = 1 ng/ml diagnose distant metastasis randomisation ( osseous systemic ) perform PET/CT randomisation malignant slave tumor potent men willing unable apply consequent contraception ongoing drug and/or alcohol abuse patient willing able cooperate accord protocol patient care patient able understand German language</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>biochemical recurrence</keyword>
	<keyword>prostate carcinoma</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>PSA</keyword>
	<keyword>postoperative</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>image diagnostic</keyword>
	<keyword>PET/CT</keyword>
	<keyword>social economic aspect</keyword>
	<keyword>quality life</keyword>
</DOC>